| |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Triplice terapia nella BPCO
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Terapia antiandrogenica nel canco prostatico recidivo
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Aspirina e FANS per prevenzione recidive del K del colon
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Poco utile la profilassi delle TVP dopo artroscopia del ginocchio
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Inibitori di pompa protonica e polmonite
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Nuove linee guida GOLD sulla BPCO - Seconda parte
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Acne: linee guida a confronto
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Nuove linee guida GOLD sulla BPCO (parte prima)
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
![](themes/Slash/images/cl.gif) ![](themes/Slash/images/pix.gif) |
Pericarditi ricorrenti: utile l' Anakinra
|
| ![](themes/Slash/images/pix.gif) ![](themes/Slash/images/cr.gif) |
Pagina precedente Pagina successiva
| |
![](themes/Slash/images/pix.gif) |
![](themes/Slash/images/pix.gif) |
Al momento non ci sono contenuti in questo blocco. |
|
![](themes/Slash/images/pix.gif) |
![](themes/Slash/images/pix.gif) |
|